Pythium insidiosum Keratitis: Past, Present, and Future

Bharat Gurnani1, Kirandeep Kaur2, Shweta Agarwal3

  • 1Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, 605007, India. drgurnanibharat25@gmail.com.

Insights

Pythium insidiosum keratitis mimics fungal infections, posing diagnostic challenges. Antibacterials show promise, and therapeutic keratoplasty is vital for severe cases.

Area of Science:

  • Ophthalmology
  • Medical Mycology
  • Infectious Diseases

Background:

  • Pythium insidiosum (PI) is an oomycete causing severe keratitis, often mistaken for fungal keratitis (FK).
  • PI keratitis, initially geographically limited, has seen a significant increase, particularly in India.
  • Its clinical presentation mimics FK, necessitating high suspicion for accurate diagnosis.

Purpose of the Study:

  • To review the evolution, diagnosis, and treatment of Pythium insidiosum keratitis.
  • To highlight diagnostic challenges and emerging therapeutic strategies.
  • To discuss future directions in PI keratitis management.

Main Methods:

  • Literature review of recent studies on PI keratitis.
  • Analysis of clinical features, diagnostic modalities, and treatment outcomes.
  • Comparison of PI keratitis with fungal keratitis.

Main Results:

  • PI keratitis presents with unique features like reticular dot infiltrate and peripheral thinning.
  • Microscopic examination and culture can be misleading; PCR is the current gold standard for diagnosis.
  • Antifungals are ineffective; antibacterials demonstrate therapeutic potential.

Conclusions:

  • Accurate diagnosis of PI keratitis is crucial due to its distinct etiology and treatment requirements.
  • Current management focuses on antibacterials and surgical intervention (keratoplasty) for advanced cases.
  • Further research is needed for improved diagnostic tools and standardized treatment protocols for PI keratitis.